Hedge Fund Industry News
A collection of Hedge Fund latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Why is Acadia Healthcare Company (ACHC) Highly Favored by Hedge Funds
Acadia Healthcare Company Inc. (NASDAQ: ACHC) is one of the 10 most promising mid-cap healthcare stocks according to hedge funds. On May 4, following a strong first-quarter report, Raymond James upgraded its rating on Acadia Healthcare Company…
Bitcoin ETF Ownership Shifts as Hedge Funds Sell and Banks Buy: CoinShares
Professional ownership of US spot Bitcoin exchange-traded funds (ETFs) declined sharply in the first quarter as Bitcoin's bear market deepened, suggesting that trading-oriented institutions were a significant source of selling pressure during the…
Why Are Investors Turning Bullish on Littelfuse (LFUS)?
The Mairs & Power, an investment firm, released the first-quarter 2026 investor letter for the “Mairs & Power Balanced Fund.” A copy of the letter can be downloaded here. The fund returned -1.77% in the first quarter of 2026…
Hong Kong's proposed fund talent tax break set to sharpen edge over Singapore
Hong Kong is set to attract top global fund managers to relocate to the city, as they will no longer need to pay salaries tax on performance-linked bonuses if they meet certain criteria under a proposed law change to be submitted to the Legislative…
Meet the big winners of 2026 oil price volatility - and why their strategies are now shifting focus
Quantitative hedge funds have posted double-digit gains in 2026 boosted by strong trends across commodities, currencies and other asset classes. Energy has been a key driver of returns, with many strategies profiting from long bets in crude oil…
Berkshire Hathaway Inc. New (BRK-B) Stock Forecasts
Berkshire Hathaway is a holding company with subsidiaries in a diverse range of industries, including insurance, railroads, utilities, energy, finance, manufacturing, and retailing. Its major subsidiaries include GEICO, Burlington Northern Santa…
Trader who sparked the Beyond Meat short-squeeze reveals why he's betting against three top AI stocks
Dimitri Semenikhin is the trader who kicked off the last year's short-squeeze in Beyond Meat stock, but these days, he's taking a more bearish view of a trio of AI infrastructure stocks. Semenikhin wrote on X this week that he's betting against…
Dyne Therapeutics (DYN) Reaches Key Regulatory Milestone
Dyne Therapeutics Inc. (NASDAQ: DYN) is one of the 10 most promising mid-cap healthcare stocks according to hedge funds. On May 26, Dyne Therapeutics Inc. (NASDAQ:DYN) reached a major regulatory milestone by submitting its official Biologics…
Here is What Makes Hinge Health (HNGE) a Promising Mid-Cap Healthcare Stock
Hinge Health Inc. (NYSE: HNGE) is one of the 10 most promising mid-cap healthcare stocks according to hedge funds. On May 7, Citizens maintained an Outperform rating for Hinge Health Inc. (NYSE:HNGE) while increasing the price target from $65 to…
Mineralys Therapeutics (MLYS) Shares Encouraging Data for Lorundrostat Clinical Efficacy
Mineralys Therapeutics Inc. (NASDAQ: MLYS) is one of the 10 most promising mid-cap healthcare stocks according to hedge funds. On May 30, Mineralys Therapeutics Inc. (NASDAQ:MLYS) provided compelling data for the clinical efficacy of lorundrostat…
Dianthus Therapeutics (DNTH) Appears Attractive Amid Solid Product Pipeline
Dianthus Therapeutics Inc. (NASDAQ: DNTH) is one of the 10 most promising mid-cap healthcare stocks according to hedge funds. On May 7, Raymond James increased its price target on Dianthus Therapeutics Inc. (NASDAQ:DNTH) from $123 to $125. The firm…
What Makes Nektar Therapeutics (NKTR) a Promising Mid-Cap Healthcare Stock
Nektar Therapeutics (NASDAQ: NKTR) is one of the 10 most promising mid-cap healthcare stocks according to hedge funds. On May 11, Wedbush analyst Martin Fan decreased the price target on Nektar Therapeutics (NASDAQ:NKTR) from $95 to $80 while…
Praxis Precision Medicines (PRAX) Shares Phase 2/3 POWER1 Study Findings
Praxis Precision Medicines Inc. (NASDAQ: PRAX) is one of the 10 most promising mid-cap healthcare stocks according to hedge funds. On June 2, Praxis Precision Medicines Inc. (NASDAQ:PRAX) published the findings of its extensive Phase 2/3 POWER1…
Erasca Inc. (ERAS) Inspiring Confidence Through Commercial Collaborations
Erasca Inc. (NASDAQ: ERAS) is one of the 10 most promising mid-cap healthcare stocks according to hedge funds. On May 11, Erasca Inc. (NASDAQ:ERAS) announced a supply agreement and a clinical trial partnership with Merck. The collaboration is aimed…
Institutional Confidence in GTX-102 Fuels Optimism for Ultragenyx Pharmaceutical (RARE)
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is one of the 10 most promising mid-cap healthcare stocks according to hedge funds. On May 21, Cantor Fitzgerald analyst Kristen Kluska maintained an Overweight rating on Ultragenyx Pharmaceutical Inc.
Receive a Daily briefing on Hedge Fund Industry News
Get Started